№ files_lp_4_process_1_51496
File format: docx
Character count: 4752
File size: 354 KB
Form used to request hepatitis B immunoglobulin and vaccination for newborns of mothers with high infectivity, providing patient, maternal, and delivery details along with administration instructions and emergency procedures.
Year:
2026
Region / City:
United Kingdom
Subject:
Perinatal Hepatitis B Prevention
Document Type:
Medical Request Form
Institution:
NHS
Author:
Healthcare Practitioner
Target Audience:
Hospital staff and pharmacists
Period of Use:
Antenatal and postnatal period
Date of Issue:
2026
Instructions Included:
Yes
Emergency Procedures:
Yes
Vaccine Administration Guidelines:
Yes
Maternal Antiviral Treatment Recorded:
Yes
Infant Delivery and Health Data:
Yes
Form Submission Method:
Email
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Version:
V3.0
Author:
Dr Julia Sikorska, Consultant Haematologist, STSTN Clinical Guidelines Group
Note:
2019
Executive/Divisional sponsor:
Via Hospital Transfusion Committee
Applies to:
All staff involved in the care of patients with Sickle Cell Disease
Date issued:
V3.0 February 2020
Review date:
February 2023
Approval person/Committee:
Hospital Transfusion Committee
Date:
March 2020
Year:
2020
Region / city:
St George’s, UK
Topic:
Hyperhaemolysis management in Haemoglobinopathies
Document type:
Clinical guidelines
Organization / institution:
St George’s University Hospitals NHS
Target audience:
Healthcare staff involved in the care of Sickle Cell Disease patients
Effective period:
February 2020–February 2023
Approval date:
March 2020
Year:
2024
Region / city:
Canberra
Topic:
Immunology, Blood Products
Document Type:
Procedure
Organization / Institution:
Canberra Health Services
Author:
Not specified
Target Audience:
Medical Officers, Nurses, Midwives, Students under direct supervision
Period of validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2026
Region / City:
Australia
Theme:
Medical Travel, Blood Products, SCIg
Document Type:
Official Guidelines
Organization / Institution:
Australian Red Cross Lifeblood, National Blood Authority, Victorian Government Department of Health
Author:
Victorian Government, Department of Health
Target Audience:
Medical professionals, Patients requiring SCIg
Period of Validity:
Not specified
Date of Approval:
January 2026
Date of Last Update:
January 2026
Year:
2023
Country:
Australia
Document type:
Clinical guidance
Organization:
Australian Government Department of Health / Blood Service
Target audience:
Healthcare professionals administering IVIg
Scope:
IVIg administration, safety, and monitoring
Effective from:
April 2023
References:
Criteria for the clinical use of intravenous immunoglobulin in Australia, 3rd edition, October 2018; Product information sheets of Privigen®AU, Kiovig®, Flebogamma®, Gammunex®, Octagam®
Appendices:
Product comparison, infusion rate guides
Date:
March 2023
Country:
Australia
Subject:
Intravenous immunoglobulin administration
Document type:
Clinical practice guidance
Healthcare setting:
Hospital and health services
Target audience:
Healthcare professionals involved in IVIg prescribing and administration
Regulatory context:
BloodSTAR authorization and national IVIg criteria
Products referenced:
Privigen®, Kiovig®, Flebogamma®, Gammunex®, Octagam®, Intragam®10
Effective period:
From April 2023
Clinical scope:
Indications, precautions, preparation, infusion, storage, and adverse effects
Source type:
Official guidance
Year:
Not specified
Region / City:
Not specified
Subject:
Tetanus prevention, immunization, post-exposure prophylaxis
Document Type:
Medical guideline
Organization / Institution:
Not specified
Author:
Not specified
Target Audience:
Healthcare professionals, medical practitioners
Period of validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2004-2016
Region / City:
Queensland, Australia
Topic:
Public health, immunoglobulin use
Document Type:
Research paper
Organization / Institution:
Griffith University, The Prince Charles Hospital, National Blood Authority
Author:
Megan K Young, Allan W Cripps, Graeme R Nimmo
Target Audience:
Public health professionals, researchers
Effective Period:
2004-2016
Approval Date:
N/A
Date of Revisions:
N/A
Year:
2026
Region / City:
United Kingdom
Topic:
Veterinary Immunology / Equine Asthma
Document Type:
Research Article
Institution:
University Veterinary Research Center
Authors:
[Not specified in document]
Target Audience:
Veterinary researchers, equine clinicians
Study Period:
Not explicitly stated
Sample Size:
12 horses (6 sEA-affected, 6 healthy controls)
Methodology:
Protein microarray-based IgE profiling
Key Findings:
Identification of novel allergens associated with severe equine asthma, reproducibility and specificity of microarray validated
Year:
2026
Region / City:
Western Australia
Subject:
Public Health, Rabies Immunoglobulin Supply
Document Type:
Guidelines, Information for Doctors
Organization:
Government of Western Australia, Department of Health
Author:
Department of Health, Public Health and Clinical Services, Communicable Disease Control Directorate
Target Audience:
Public Health Units, On-call Doctors
Period of Validity:
Ongoing
Approval Date:
Not specified
Amendment Date:
Not specified
Year:
2026
Region / City:
Kansas, USA
Topic:
Maternal and Child Health, Substance Use Screening
Document Type:
Model Policy Template
Organization / Agency:
Kansas Department of Health, Bureau of Family Health
Target Audience:
Healthcare providers serving perinatal and postpartum women
Effective Period:
From implementation date, ongoing
Related Materials:
SBIRT Integration Toolkit, ASSIST Screening Tool, Crisis Intervention Algorithm, Consent Forms
Year:
2025
Jurisdiction:
Los Angeles County, California
Issuing body:
Los Angeles County Department of Public Health
Program:
Comprehensive Perinatal Services Program (CPSP)
Document type:
Program protocols
Date issued:
April 14, 2025
Addressing population:
Prenatal and postpartum clients
Intended users:
CPSP providers and practitioners
Subject areas:
Prenatal care, postpartum care, nutrition, psychosocial assessment, health education
Related references:
CPSP Provider Handbook (2018 Edition); CPSP Steps to Take Guidelines (2019 Edition)
Geographic scope:
Los Angeles County
Year:
2025-2026
Region / City:
Victoria, Australia
Topic:
Perinatal data collection
Document type:
Manual
Organization / Institution:
Department of Health, Victoria
Author:
Victorian Government
Target audience:
Healthcare professionals, software vendors, government agencies
Period of validity:
2025-2026
Approval date:
June 2025
Date of last change:
Not specified
Year:
2024
Region / City:
Fresno County
Topic:
Maternal Health, Perinatal Care
Document Type:
News Update
Organization:
Fresno County Maternal & Preventative Care Committee
Author:
Yvonne Lopez
Target Audience:
Health professionals, women, and families in Fresno County
Effective Period:
November 2024
Approval Date:
November 1, 2024
Date of Changes:
N/A
Year:
2022
Region / Country:
Scotland, UK
Topic:
Perinatal and infant mental health
Document type:
Guidelines
Commissioning body:
Scottish Government Perinatal and Early Years Mental Health Team
Authors:
See Me; Mental Health Foundation (MHF)
Target audience:
Healthcare practitioners, commissioners, service providers, midwives, health visitors, mental health nurses, GPs, social workers
Period covered:
April 2022 – October 2022
Date of publication:
October 2022
Related resources:
Accompanying literature review, good practice case studies
Year:
2016
Region / City:
Louisiana
Topic:
Neonatal Abstinence Syndrome, Opioid Abuse Prevention, Perinatal Health
Document Type:
Meeting Notes
Agency / Organization:
Louisiana Department of Health, Louisiana Commission on Perinatal Care and Prevention of Infant Mortality
Author:
Rebekah E. Gee, Michelle Alletto, Berkeley Durbin, others
Target Audience:
Health professionals, government officials, legislative committees
Action Period:
July 14, 2016
Approval Date:
July 14, 2016
Date of Changes:
None
Year:
2022
Region / City:
Victoria, Australia
Topic:
Health Data Collection, Perinatal Care
Document Type:
Official Proposal, Feedback Request
Organization:
Department of Health, Victorian Government
Author:
Not specified
Target Audience:
Clinical professionals, health service providers
Effective Period:
From 1 July 2023
Approval Date:
October 2022
Feedback Deadline:
Friday 21 October 2022
Date of Release:
Early December 2022
Year:
2024–2025
Region / City:
Bradford, Airedale, Leeds, Calderdale, Kirklees, Wakefield
Subject:
Perinatal mental health, birth trauma, baby loss, severe fear of pregnancy and birth
Document Type:
Referral form
Organization / Institution:
NHS West Yorkshire PATHs Service
Author:
Multidisciplinary team including psychologists, psychological therapists, midwives, and administrative staff
Target Audience:
Women and birthing people experiencing moderate to severe perinatal mental health symptoms
Service Hours:
Monday–Friday, 9am–5pm
Referral Pathways:
Baby loss, birth trauma, severe fear of pregnancy/birth, parent-infant separation at birth (from 2025)
Exclusion Criteria:
Crisis support, self-harm or suicidal ideation, sudden severe mental health onset, parent-infant relationship issues only, current untreated substance misuse
Assessment Timeline:
New referrals assessed within six weeks
Contact Email:
[email protected]
Year:
2021
Region / City:
Scotland
Theme:
Mental Health
Document Type:
Application Form
Organization:
Inspiring Scotland
Target Audience:
Incorporated organizations with annual income up to £1 million, registered with the Scottish Charity Regulator (OSCR)
Period of Validity:
From October 2021 to March 31, 2022
Approval Date:
Not specified
Amendment Date:
Not specified
Description:
Application form for organizations seeking funding for perinatal and infant mental health projects, outlining required financial information and project details.
Year:
2022
Region / city:
Scotland
Theme:
Perinatal and infant mental health
Document type:
Guidelines
Organization / institution:
Scottish Government, See Me, Mental Health Foundation (MHF)
Author:
Mental Health Foundation
Target audience:
Healthcare practitioners, commissioners, and providers of perinatal and infant mental health services
Effective period:
2022
Approval date:
April 2022
Modification date:
N/A